Antivascular Endothelial Growth Factor Agents for Neovascular Age-Related Macular Degeneration

Antivascular Endothelial Growth Factor Agents for Neovascular Age-Related Macular Degeneration

Age-related macular degeneration (AMD) is the leading cause of severe visual loss and blindness over the age of 50 in developed countries. Vascular endothelial growth factor (VEGF) is considered as a critical molecule in the pathogenesis of choroidal neovascularization (CNV), which characterizes the...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ilias Zampros, Anna Praidou, Periklis Brazitikos, Panagiotis Ekonomidis, Sofia Androudi
Format:	Article
Language:	English
Published:	Wiley 2012-01-01
Series:	Journal of Ophthalmology
Online Access:	http://dx.doi.org/10.1155/2012/319728
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy and Safety of Antivascular Endothelial Growth Factor (Anti-VEGF) in Treating Neovascular Age-Related Macular Degeneration (AMD): A Systematic Review and Meta-analysis
by: Xiaobei Yin, et al.
Published: (2022-01-01)

Long-Term Visual Outcomes for a Treat-and-Extend Antivascular Endothelial Growth Factor Regimen in Eyes with Neovascular Age-Related Macular Degeneration: Up to Seven-Year Follow-Up
by: Simon Javidi, et al.
Published: (2020-01-01)

Role of Intravitreal Antivascular Endothelial Growth Factor Injections for Choroidal Neovascularization due to Choroidal Osteoma
by: Ahmad M. Mansour, et al.
Published: (2014-01-01)

Diabetic Retinopathy Treated with Laser Photocoagulation and the Indirect Effect on Glycaemic Control
by: Anna Praidou, et al.
Published: (2014-01-01)

Sustained and Efficient Delivery of Antivascular Endothelial Growth Factor by the Adeno-associated Virus for the Treatment of Corneal Neovascularization: An Outlook for Its Clinical Translation
by: Mengzhen Xie, et al.
Published: (2024-01-01)

OCT Biomarkers in Neovascular Age-Related Macular Degeneration: A Narrative Review
by: Cristian Metrangolo, et al.
Published: (2021-01-01)

Treatment of Neovascular Age-Related Macular Degeneration with Anti-VEGF Agents: Predictive Factors of Long-Term Visual Outcomes
by: Ana Catarina Pedrosa, et al.
Published: (2017-01-01)

Choroidal Vascularity Index as a Biomarker for Visual Response to Antivascular Endothelial Growth Factor Treatment in Diabetic Macular Edema
by: Ningxin Dou, et al.
Published: (2021-01-01)

Neovascular age-related macular degeneration: disease pathogenesis and current state of molecular biomarkers predicting treatment response—a scoping review
by: Nikolaos Dervenis, et al.
Published: (2024-05-01)

Comparison of optical coherence tomography vs. fluorescein angiography-based macular neovascularization classifications in age-related macular degeneration
by: Gábor G. Deák, et al.
Published: (2025-02-01)

Intravitreal Aflibercept Outcomes in Patients with Persistent Macular Exudate Previously Treated with Bevacizumab and/or Ranibizumab for Neovascular Age-Related Macular Degeneration
by: David R. Griffin, et al.
Published: (2014-01-01)

The Diagnostic Capability of Swept Source OCT Angiography in Treatment-Naive Exudative Neovascular Age-Related Macular Degeneration
by: Daniel Ahmed, et al.
Published: (2021-01-01)

Response to Aflibercept Therapy in Three Types of Choroidal Neovascular Membrane in Neovascular Age-Related Macular Degeneration: Real-Life Evidence in the Czech Republic
by: Jan Nemcansky, et al.
Published: (2019-01-01)

Efficacy and safety of faricimab for neovascular age-related macular degeneration: a systematic review and network meta-analysis
by: Francisco Rodríguez, et al.
Published: (2024-05-01)

Zoledronic acid as adjuvant therapy in neovascular age-related macular degeneration: a randomised controlled pilot study
by: Øystein Kalsnes Jørstad, et al.
Published: (2024-12-01)

Gene Therapy with Endogenous Inhibitors of Angiogenesis for Neovascular Age-Related Macular Degeneration: Beyond Anti-VEGF Therapy
by: Selwyn M. Prea, et al.
Published: (2015-01-01)

The Effect of Antivascular Endothelial Growth Factor on the Development of Adhesion Formation in Laparotomized Rats: Experimental Study
by: Murat Basbug, et al.
Published: (2011-01-01)

Treatment for Nontype 1 Retinopathy of Prematurity by Intravitreal Injection of Antivascular Endothelial Growth Factor Drugs
by: Haitao Zhang, et al.
Published: (2022-01-01)

Joint Effect of CFH and ARMS2/HTRA1 Polymorphisms on Neovascular Age-Related Macular Degeneration in Chinese Population
by: Kai Fang, et al.
Published: (2015-01-01)

Short-Term Results of Switch from Conbercept to Bevacizumab or Ranibizumab in Eyes with Persistent Neovascular Age-Related Macular Degeneration
by: Zongyi Wang, et al.
Published: (2020-01-01)

Predictive value of different baseline optical coherence tomography biomarkers for visual acuity changes in neovascular age-related macular degeneration
by: Hamid Riazi-Esfahani, et al.
Published: (2025-02-01)

Comparison of Progression Rate of Retinal Pigment Epithelium Loss in Patients with Neovascular Age-Related Macular Degeneration Treated with Ranibizumab and Aflibercept
by: Juliana Wons, et al.
Published: (2017-01-01)

Emotional and physical experiences of people with neovascular age-related macular degeneration during the injection process in Germany: a qualitative study
by: Oliver Zeitz, et al.
Published: (2022-06-01)

Is It Safe to Restart Antivascular Endothelial Growth Factor Therapy in Patients with Renal Cell Carcinoma after Cardiac Ischemia?
by: Bo Zhao, et al.
Published: (2015-01-01)

Chinese Herbal Medicine Combined with Intravitreal Antivascular Growth Factor Agents in Treatment of Macular Edema Secondary to Retinal Vein Occlusion: A Systematic Review and Meta-Analysis
by: Su Xiaojuan, et al.
Published: (2022-01-01)

Relationship between Neovascular Density in Swept Source-Optical Coherence Tomography Angiography and Signs of Activity in Exudative Age-Related Macular Degeneration
by: Martin Stattin, et al.
Published: (2019-01-01)

Use of Imaging Modalities in Real Life: Impact on Visual Acuity Outcomes of Ranibizumab Treatment for Neovascular Age-Related Macular Degeneration in Germany
by: Joachim Wachtlin, et al.
Published: (2020-01-01)

Three-Year Outcomes of Patients with Neovascular Age-Related Macular Degeneration Treated with Aflibercept under the National Health Insurance Program in Taiwan
by: Kang-Jung Lo, et al.
Published: (2020-01-01)

Opportunities, challenges, and difficulties in NMR-based metabolomics applied to neovascular age-related macular degeneration (nAMD) patient follow-up
by: M. Schoumacher, et al.
Published: (2025-01-01)

Two-Year Outcome of Aflibercept in Patients with Pigment Epithelial Detachment due to Neovascular Age-Related Macular Degeneration (nAMD) Refractory to Ranibizumab
by: Thi Ha Chau Tran, et al.
Published: (2017-01-01)

Efficacy Comparison of Intravitreal Anti-VEGF Therapy for Three Subtypes of Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis
by: Jianqing Li, et al.
Published: (2018-01-01)

Intraocular inflammation after intravitreal injection of aflibercept 8 mg for treatment-refractory neovascular age-related macular degeneration: a case report
by: Nozomu Hashiya, et al.
Published: (2025-01-01)

Mechanism of Inflammation in Age-Related Macular Degeneration
by: Francesco Parmeggiani, et al.
Published: (2012-01-01)

Corrigendum to “Two-Year Outcome of Aflibercept in Patients with Pigment Epithelial Detachment due to Neovascular Age-Related Macular Degeneration (nAMD) Refractory to Ranibizumab”
by: Thi Ha Chau Tran, et al.
Published: (2018-01-01)

Anti-vascular Endothelial Growth Factor Outpatient Treatment Patterns in Patients with Exudative Age-related Macular Degeneration from a Japanese Hospital Claims Database
by: Tomohiro Iida, et al.
Published: (2014-07-01)

Six-Year Real-World Outcomes of Antivascular Endothelial Growth Factor Monotherapy and Combination Therapy for Various Subtypes of Polypoidal Choroidal Vasculopathy
by: Jingyuan Yang, et al.
Published: (2019-01-01)

A Meta-Analysis of Studies Evaluating Visual and Anatomical Outcomes in Patients with Treatment Resistant Neovascular Age-Related Macular Degeneration following Switching to Treatment with Aflibercept
by: Sophie Seguin-Greenstein, et al.
Published: (2016-01-01)

Age-Related Macular Degeneration: Insights into Inflammatory Genes
by: Raffaella Cascella, et al.
Published: (2014-01-01)

Future Therapies of Wet Age-Related Macular Degeneration
by: Makoto Ishikawa, et al.
Published: (2015-01-01)

Ocular Surface Temperature in Age-Related Macular Degeneration
by: Andrea Sodi, et al.
Published: (2014-01-01)